Breast Augmentation in Turkey
Breast Augmentation plastic surgery in Turkey section, includes general infrmation about Breast Augmentation Procedure, Breast Augmentation Turkey Local News, Breast Augmentation Turkey Surgeon Locator and other breast augmentation related materal.
Turkey Breast Augmentation - The Plastic Surgery Procedure
The plastic surgery operation is usually done when the breast reaches its final size after puberty (ages 17-18). Except for cases when there is congenital breast hypoplasia or breast asymmetry in which it can be done earlier (local regulations in Turkey may be applicable).
Turkey breast augmentation - the implants
There are three possible areas for the insertion of an implant for augmentation. The lower fold of the breast is the most common site. It allows full excess and lives a hidden scar. The second site is through the areola. This incision gives the best esthetic results but it is also the only one that goes through the breast tissue therefore the risk of infection and sensation loss is higher. The third one is through the armpits. Some plasit surgeons prefer it because the scar is almost invisible (except for those women who like to wear open close with no sleeves(. The disadvantage of this incision is a slight asymmetry of the breast. The decision usually made individually with each woman and the plastic surgeon (consult local Turkey surgeons).
The augmentation implant can be inserted above or below the chest muscles. The below position considered to be more preferable by most Turkey surgeons. There is less chance of feeling the implant, less chance of developing irregular folds or bumps on the surface of the breast and the implant is less likely to drop. This kind of plastic surgery technique is suitable for women with relatively little extra skin and less fallen breasts.
Most of the implants are made of silicon, and since the FDA determined that they safe for use they are being widely used by most plastic surgeons in Turkey.
[breast augmentation Turkey top]
Turkey breast augmentation - shape and size
The augmentation implants come in two shapes: round and pear shape also called "anatomic implants" because their shape resembles the natural contour of the breast. They are more expensive and require larger excision during the breast augmentation plastic surgery procedure.
The size of an implant usually depends on the woman size and proportions, the average size is 300cc. It is believed that smaller implants have lower complications.
[breast augmentation Turkey top]
Turkey breast augmentation - after the plastic surgery
After the augmentation plastic surgery you'll be wearing a sports bra or a bandage. You'll continue wearing them at all times day and night for about a month. You'll be able to take a shower 24 hours after the plastic surgery. The most optimal results usually seen 3 month after the surgery. Several things can complicate this plastic surgery procedure; those are rare complications, which you should be aware off. Bleeding around the area of the implant, infection, disturbances of sensation and touch around the nipples, silicon leak, rejection off an implant and some degree of irregularity on the surface of an implant.
Other Breast Augmentation Procedures
All Breast Plastic Surgery Procedures
Turkey Breast augmentation Plastic Surgery (current)
Turkey Breast Lift Plastic Surgery
Turkey Breast Implants Plastic Surgery
Turkey Implant Removal Plastic Surgery
Turkey Armpit Incision Plastic Surgery
More Turkey info...
Turkey Get in Before visiting Turkey, you should check the E-Consulate website to determine if you need a visa, and if so the fees.
Citizens of the following countries need visas, and can get a sticker-type entry visa at the point of entry into Turkey for a fee:
Valid for three months:
UK (cost: US$20 / €15 / £10)
US (cost: US$20)
Canada (cost: €45)
Australia (cost: $20 / €15)
Ireland
The Netherlands (cost: €10)
Italy (cost: €10)
Portugal (cost: €10) Valid for two months:
Ukraine (cost: US$20) Valid for one month:
Azerbaijan, Moldova, Russia (cost: EUR10 or US$15)
Serbia (cost: 10 euros) German visitors can enter even with their identity card (Personalausweis) unless they arrive at the non-Council of Europe land border crossings (i.e. to Iran, Iraq and Syria). (Reference needed).
Turkey Holidays Ramadan dates
2007 (1428): Sep 13 - Oct 11
2008 (1429): Sep 1 - Sep 29
2009 (1430): Aug 21 - Sep 19 Exact dates depend on astronomical observations and may vary from country to country.
Official holidays
Jan 1: New Year's Day National holidays
Apr 23: National Sovereignty and Children's Day (anniversary of the establishment of the Turkish Grand National Assembly)
May 19: Atat?rk Commemoration and Youth & Sports Day (the arrival of Atat?rk in Samsun, and the beginning of the War of Independence)
Aug 30: Victory Day (victory over invading forces in 1922).
Oct 29: Republic Day (anniversary of the declaration of the Turkish Republic) Religious holidays
Seker Bayrami: Three-day festival during which sweets are eaten to celebrate the end of the fast of Ramadan.
Kurban Bayrami: Four-day festival when sacrificial sheep are slaughtered and their meat distributed to the poor.
Breast AugmentationLatest Forum Posts...
- Good morning to everyone!
I hope that this post isn’t “out” here. I would like just to say that if someone of you are thinking to have plastic surgery operations but they are very expensive, there’s something new for you:
Plastic Surgery News...
- Three-year results reported from a controlled trial of etanercept plus methotrexate (MTX) in patients with rheumatoid arthritis (RA) confirm the continued efficacy of the combination against monotherapy, with no unexpected adverse effects.
The TEMPO trial was planned from outset as a longer-term, three-year study. It compared etanercept plus MTX against either drug as monotherapy in adult patients with active RA not responding to at least one previous DMARD other than MTX. They were randomised to double-blind treatment with etanercept, MTX, or the combination; initial outcomes focussed on response to treatment using ACR criteria. For the long-term phase, the outcomes used were disease activity and remission using the Disease Activity Score (DAS); response according the ACR score was also assessed. The authors used statistical techniques that attempted to correct for biases inherent in long-term therapeutic trials.
TEMPO initially randomised 686 patients, of whom 682 received at least one dose of study drug. Over the three years, 350 patients withdrew from the trial, with more withdrawals due to inefficacy in the monotherapy groups (combination group 5% vs. 16% for etanercept and 17% for MTX). Analysis indicated that those in the combination therapy group had greater improvement in DAS and were more likely to remain in remission than those in either monotherapy group. Patients in the combination group did better than those in the monotherapy groups on most other outcomes; the combination and etanercept were both better than MTX alone for radiographic progression. Adverse effects were similar across the three groups, and no new or unexpected adverse effects were reported in year three.
Overall, the authors conclude that etanercept plus MTX combination treatment continued to show superior efficacy to monotherapy over three years, even after adjustment for withdrawals. There were no additional safety concerns.
- According to a report by BioSpace.com, Bayer Pharmaceuticals has announced that a phase III trial evaluating the use of sorafenib (Nexavar) for non-small cell lung cancer (NSCLC) has been stopped early following an interim analysis which concluded that the primary outcome of improved overall survival would not be met.
The phase III ESCAPE (Evaluation of Sorafenib, Carboplatin And Paclitaxel Efficacy in NSCLC) trial evaluated sorafenib when administered in combination with carboplatin and paclitaxel in patients with NSCLC. A higher mortality was observed in the subset of patients with squamous cell carcinoma of the lung treated with the sorafenib combination, compared to those treated with carboplatin and paclitaxel alone.